Scandi Standard (SCST) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
23 Oct, 2025Executive summary
Achieved record EBIT in Q3 2025, up 21% year-over-year, with 11% net sales growth driven by strong demand and volume increases across countries and segments.
Ready-to-Cook segment delivered significant EBIT growth, while Ready-to-Eat bottomed out with sequential improvements expected.
Successful integration and ramp-up of Lithuanian operations and earlier-than-expected startup of the Netherlands RTE plant, with further ramp-up planned for 2026.
Strategic investments in efficiency, capacity, and sustainability, especially in Sweden, Ireland, Denmark, Lithuania, and the Netherlands.
Financial highlights
Q3 2025 net sales: SEK 3,723 million (up 11%); EBIT: SEK 185 million (up 21%); EBIT margin: 5.0% (up from 4.6%).
Ready-to-Cook net sales up 13% to SEK 2,873 million; EBIT up 43% to SEK 159 million; margin at 5.5%.
Ready-to-Eat net sales up 5% to SEK 713 million; EBIT down to SEK 17 million due to input cost pressures; margin at 2.4%.
Operating cash flow Q3: SEK 189 million; leverage at 2.2x, below internal target.
Dividend per share increased to SEK 2.50, up 9% year-over-year.
Outlook and guidance
Ready-to-Eat profitability expected to recover as price increases are implemented.
Material progress anticipated in Q4 2025 and 2026, with Netherlands and Lithuanian expansions; Factory C in the Netherlands set for startup in H1 2026.
2027 targets: 5%-7% net sales growth, EBIT margin above 6%, EBIT per kg above SEK 3, and >15% ROCE.
Total 2025 capex expected at SEK 450 million, with some investments deferred to 2026.
Blended effective tax rate expected at 20%.
Latest events from Scandi Standard
- Q4 profit and sales surged, margins improved, and dividend rose 32% with strong 2026 outlook.SCST
Q4 20255 Feb 2026 - Q2 EBIT rose 5% to SEK 127m, margin hit 3.8%, driven by Ready-to-Cook and efficiency gains.SCST
Q2 20243 Feb 2026 - Adjusted EBIT up 18% with margin gains and Lithuanian acquisition boosting future growth.SCST
Q3 202418 Jan 2026 - Sales and EBIT rose, with acquisitions and investments driving future growth.SCST
Q1 202523 Dec 2025 - Record Q4 sales and EBIT, with acquisitions and higher dividend supporting future growth.SCST
Q4 202423 Dec 2025 - Record EBIT and 6% sales growth in Q2, with strong demand and positive Lithuania ramp-up.SCST
Q2 202516 Nov 2025